Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Vale Indonesia Tbk. (INCO) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Vale Indonesia Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Vale Indonesia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Vale Indonesia Tbk. trades at Rp5,325 (market cap 52.7T, 8.46M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp167 (market cap 651.75B, 626.9K 24h volume). The key difference: Vale Indonesia Tbk. is far larger — about 80.9× UBC Medical Indonesia Tbk.'s market cap, and Vale Indonesia Tbk. is more actively traded (8.46M versus 626.9K). Which is the better fit depends on your goals.

INCOLABS
Market Cap
52.7T651.75B
Volume
8.46M626.9K
Lot
84.59K6.27K
Turnover
43.77B103.6M
Average Price
5,173.85165.25
Value
43.77B103.6M
Indicative Equilibrium Price
5,000165
Indicative Equilibrium Volume
55.4K300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

INCO
View details
LABS
View details

About Vale Indonesia Tbk.

PT Vale Indonesia Tbk, formely PT International Nickel Indonesia, was established on July 25, 1968. PT. INCO produces nickel in matte, an intermediate product, from lateritic ores at its integrated mining and processing facilities near Soroako on the island of Sulawesi. The company is owned 58.7 % by Inco Limited of Canada, 20.1 % by Sumitomo Metal Mining Co., Ltd. of Japan.The Company is PMA

Read more on INCO

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS